Previous work suggests that the presence of inflammation in post-menopausal breast cancer is associated with a poor response to aromatase inhibitor treatment. Here, an anti-inflammatory drug aspirin is given with the aromatase inhibitor, and the breast cancer will be sampled before and after the treatment, given in the window of time between diagnosis and definitive surgery.
Key inclusion criteria
Key exclusion criteria
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at firstname.lastname@example.org
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to email@example.com
Subscribe for updates & stay in the loop with new studies.